期刊文献+

Laparoscopic Liver Resection: A Tool to Improve Outcomes in Obese Patients Requiring Liver Resection

Laparoscopic Liver Resection: A Tool to Improve Outcomes in Obese Patients Requiring Liver Resection
暂未订购
导出
摘要 Introduction: Obesity is associated with an increased risk of fatty liver disease, predisposing to liver fibrosis and cirrhosis, as well as increased occurrence of hepatocellular carcinoma. Obesity is intuitively considered a risk factor for increased post-hepatectomy morbidity and mortality. Nevertheless, peer-reviewed literature reveals significant heterogeneity between different cohorts contributing to varying conclusions. Outcomes in this cohort for Laparoscopic Liver Resection (LLR), especially in non-academic settings remain under-evaluated. The current study evaluated outcomes of LLR in obese patients, in a community health system. Methods: A retrospective analysis of all patients undergoing LLR at the flagship hospital in the community health system, between 2013 and 2020, was performed. Classified into two groups based on Body Mass Index (BMI): obese (BMI > 30 kg/m<sup>2</sup>) vs non-obese (BMI Results: 90 patients underwent LLR during the 7-year period;obese = 38 and non-obese = 52. No statistically significant differences were noted between obese and non-obese cohorts, in baseline characteristics including age (53.1 ± 15.1 vs 56.8 ± 11.6 years), female gender (60.5% vs 53.8%), and ASA grade (3.13 ± 0.53 vs 3.02 ± 0.54) (all p > 0.05). Univariate analysis showed no statistically significant differences between obese and non-obese groups, comparing estimated blood loss [300 (100 - 500) vs. 200 (100 - 462.5) cc], operative time [177 (125 - 215) vs. 150.9 (111 - 207) minutes], bile leak (2.6% vs. 4.1%), post-operative bleeding (2.6% vs. 4.1%), infection (0% vs. 4.1%), cardiorespiratory complication (10.5% vs 12.2%), conversion rate (5.3% vs 5.8%), length of stay [4 (3 - 5) vs. 4 (2 - 5) days], 90-day reoperation (0% vs. 2%) and 90-day readmission (2.6% vs. 4.1%) (p > 0.05). Multivariate analysis showed no association between obesity and composite complication rate (p = 0.97), after adjusting for alcohol abuse, neoadjuvant therapy, and prior liver surgery. Conclusion: LLR is a key technique that can be replicated in the community setting to improve outcomes in obese patients requiring liver resection. Larger prospective multicenter studies are warranted to externally validate these findings. Introduction: Obesity is associated with an increased risk of fatty liver disease, predisposing to liver fibrosis and cirrhosis, as well as increased occurrence of hepatocellular carcinoma. Obesity is intuitively considered a risk factor for increased post-hepatectomy morbidity and mortality. Nevertheless, peer-reviewed literature reveals significant heterogeneity between different cohorts contributing to varying conclusions. Outcomes in this cohort for Laparoscopic Liver Resection (LLR), especially in non-academic settings remain under-evaluated. The current study evaluated outcomes of LLR in obese patients, in a community health system. Methods: A retrospective analysis of all patients undergoing LLR at the flagship hospital in the community health system, between 2013 and 2020, was performed. Classified into two groups based on Body Mass Index (BMI): obese (BMI > 30 kg/m<sup>2</sup>) vs non-obese (BMI Results: 90 patients underwent LLR during the 7-year period;obese = 38 and non-obese = 52. No statistically significant differences were noted between obese and non-obese cohorts, in baseline characteristics including age (53.1 ± 15.1 vs 56.8 ± 11.6 years), female gender (60.5% vs 53.8%), and ASA grade (3.13 ± 0.53 vs 3.02 ± 0.54) (all p > 0.05). Univariate analysis showed no statistically significant differences between obese and non-obese groups, comparing estimated blood loss [300 (100 - 500) vs. 200 (100 - 462.5) cc], operative time [177 (125 - 215) vs. 150.9 (111 - 207) minutes], bile leak (2.6% vs. 4.1%), post-operative bleeding (2.6% vs. 4.1%), infection (0% vs. 4.1%), cardiorespiratory complication (10.5% vs 12.2%), conversion rate (5.3% vs 5.8%), length of stay [4 (3 - 5) vs. 4 (2 - 5) days], 90-day reoperation (0% vs. 2%) and 90-day readmission (2.6% vs. 4.1%) (p > 0.05). Multivariate analysis showed no association between obesity and composite complication rate (p = 0.97), after adjusting for alcohol abuse, neoadjuvant therapy, and prior liver surgery. Conclusion: LLR is a key technique that can be replicated in the community setting to improve outcomes in obese patients requiring liver resection. Larger prospective multicenter studies are warranted to externally validate these findings.
作者 Asmita Chopra Michael Devries Rachel Mullins Roberta Redfern Kerri Ann Simo Asmita Chopra;Michael Devries;Rachel Mullins;Roberta Redfern;Kerri Ann Simo(Department of Surgery, University of Toledo School of Medicine, Toledo, Ohio;Promedica Health System, Toledo Hospital, Toledo, Ohio)
出处 《Open Journal of Gastroenterology》 CAS 2022年第12期347-360,共14页 肠胃病学期刊(英文)
关键词 Liver Resection LAPAROSCOPIC OBESITY Surgical Outcomes MINIMALLY-INVASIVE Liver Resection Laparoscopic Obesity Surgical Outcomes Minimally-Invasive
  • 相关文献

参考文献3

二级参考文献48

  • 1Víctor Vargas,Helena Allende,Albert Lecube,Maria Teresa Salcedo,Juan A Baena-Fustegueras,José M Fort,Joaquín Rivero,Roser Ferrer,Roberto Catalán,Eva Pardina,Santiago Ramón y Cajal,Jaime Guardia,Julia Peinado-Onsurbe.Surgically induced weight loss by gastric bypass improves non alcoholic fatty liver disease in morbid obese patients[J].World Journal of Hepatology,2012,4(12):382-388. 被引量:7
  • 2Joel Leroy,Pascal Ananian,Francesco Rubino,Bertrand Claudon,Didier Mutter,Jacques Marescaux.The Impact of Obesity on Technical Feasibility and Postoperative Outcomes of Laparoscopic Left Colectomy[J]. Annals of Surgery . 2005 (1)
  • 3Kevin Tri Nguyen,T Clark Gamblin,David A. Geller.World Review of Laparoscopic Liver Resection—2,804 Patients[J].Annals of Surgery.2009(5)
  • 4M. S. Mirza,K. D. Mullen,C. T. Shun,W. Vogel.Obesity, Visceral Fat, and NAFLD: Queryingthe Role of Adipokines in the Progression ofNonalcoholic Fatty Liver Disease[J].ISRN Gastroenterology.2011
  • 5Christopher D. Williams,Joel Stengel,Michael I. Asike,Dawn M. Torres,Janet Shaw,Maricela Contreras,Cristy L. Landt,Stephen A. Harrison.Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study[J].Gastroenterology.2011(1)
  • 6Donna L. White,Fasiha Kanwal,Hashem B. El–Serag.Association Between Nonalcoholic Fatty Liver Disease and Risk for Hepatocellular Cancer, Based on Systematic Review[J].Clinical Gastroenterology and Hepatology.2012(12)
  • 7A. N. Mavrogiannaki,I. N. Migdalis,Nikolaos Papanas.Nonalcoholic Fatty Liver Disease, Diabetes Mellitus and Cardiovascular Disease: Newer Data[J].International Journal of Endocrinology.2013
  • 8Shuja Hafeez,Mohamed H. Ahmed,Ahmed Almobarak.Bariatric Surgery as Potential Treatment for Nonalcoholic Fatty Liver Disease: A Future Treatment by Choice or by Chance?[J].Journal of Obesity.2013
  • 9Xin Gao,Jian‐Gao Fan.Diagnosis and management of non‐alcoholic fatty liver disease and related metabolic disorders: Consensus statement from the S tudy G roup of L iver and M etabolism, C hinese S ociety of E ndocrinology (非酒精性脂肪性肝病与相关代谢紊乱诊疗共识——中华医学会内分泌学分会肝病与代谢学组)[J].Journal of Diabetes.2013(4)
  • 10Amedeo Lonardo,Silvia Sookoian,Michel Chonchol,Paola Loria,Giovanni Targher.Cardiovascular and Systemic Risk in Nonalcoholic Fatty Liver Disease - Atherosclerosis as a Major Player in the Natural Course of NAFLD[J].Current Pharmaceutical Design.2013(29)

共引文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部